Sign in

CIK 0000882095

  • Large accelerated filer

GILEAD SCIENCES, INC.

Sign in to watch
Ticker
GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943047598
Phone
+1 650-574-3000
Business address
333 LAKESIDE DR, FOSTER CITY, CA, 94404
Former names
GILEAD SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$36,996,096
in 12 filings, $37.0M under 10b5-1 plans

Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-11-28 Kramer Kelly A. Director Option exercise 10b5-1 +2,805 $81.00 $227K 4,144
2025-11-28 Kramer Kelly A. Director Sale 10b5-1 −2,805 $127.10 $357K 1,339
2025-11-28 Kramer Kelly A. Director Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 −2,805 0
2025-11-26 Kramer Kelly A. Director Option exercise 10b5-1 +2,806 $81.00 $227K 4,145
2025-11-26 Kramer Kelly A. Director Sale 10b5-1 −2,806 $127.11 $357K 1,339
2025-11-26 Kramer Kelly A. Director Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 −2,806 2,805
2025-11-17 Mercier Johanna Chief Commercial Officer Option exercise 10b5-1 +25,000 $66.64 $1.7M 135,193
2025-11-17 Mercier Johanna Chief Commercial Officer Sale 10b5-1 −25,524 $125.83 $3.2M 109,669
2025-11-17 Mercier Johanna Chief Commercial Officer Sale 10b5-1 −2,476 $126.26 $313K 107,193
2025-11-17 Mercier Johanna Chief Commercial Officer Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 −25,000 73,110
2025-11-17 Dickinson Andrew D Chief Financial Officer Sale 10b5-1 −2,500 $125.23 $313K 154,555
2025-11-12 Telman Deborah H EVP, Corporate Affairs & GC Option exercise 10b5-1 +17,181 $75.12 $1.3M 60,857
2025-11-12 Telman Deborah H EVP, Corporate Affairs & GC Sale 10b5-1 −17,181 $124.00 $2.1M 43,676
2025-11-12 Telman Deborah H EVP, Corporate Affairs & GC Option exercise 10b5-1 +35,965 $60.75 $2.2M 79,641
2025-11-12 Telman Deborah H EVP, Corporate Affairs & GC Sale 10b5-1 −35,965 $122.30 $4.4M 43,676
2025-11-12 Telman Deborah H EVP, Corporate Affairs & GC Option exercise 10b5-1 +500 $60.75 $30K 44,176
2025-11-12 Telman Deborah H EVP, Corporate Affairs & GC Sale 10b5-1 −500 $122.90 $61K 43,676
2025-11-12 Telman Deborah H EVP, Corporate Affairs & GC Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 −17,181 37,799
2025-11-12 Telman Deborah H EVP, Corporate Affairs & GC Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 −35,965 12,655
2025-11-12 Telman Deborah H EVP, Corporate Affairs & GC Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 −500 12,155

Page 12 of 30 · 599 trades